Literature DB >> 18853166

Serum antioxidants and nitric oxide levels in fibromyalgia: a controlled study.

Omer Faruk Sendur1, Yasemin Turan, Engin Tastaban, Cigdem Yenisey, Mukadder Serter.   

Abstract

We proposed to assess antioxidant status and nitric oxide in fibromyalgia (FM) patients in comparison to healthy controls. Additionally, the association between the serum antioxidant levels and clinical findings in FM patients was also investigated. Thirty-seven FM patients and 37 healthy controls were enrolled in this study. Severity of fatigue and pain were determined by Visual Analogue Scale. Functional capacity in daily living activities was evaluated by fibromyalgia impact questionnaire. Serum NO, catalase and glutathione were measured. Serum glutathione and catalase levels were significantly lower in FM patients than controls. However, no significant difference was seen in serum NO levels between the two groups. A significant correlation was evident between serum NO level and pain. Additionally, the correlation between glutathione level and morning stiffness was found to be significant. These findings support other studies, we assume that these two antioxidants might have impact on the pathogenesis of FM disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18853166     DOI: 10.1007/s00296-008-0738-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

1.  Abnormal microcirculation and temperature in skin above tender points in patients with fibromyalgia.

Authors:  M Jeschonneck; G Grohmann; G Hein; H Sprott
Journal:  Rheumatology (Oxford)       Date:  2000-08       Impact factor: 7.580

2.  Circadian rhythms in glutathione and glutathione-S transferase activity of rat liver.

Authors:  M J Tuñón; P González; P López; G M Salido; J A Madrid
Journal:  Arch Int Physiol Biochim Biophys       Date:  1992 Jan-Feb

Review 3.  Glutathione metabolism and its implications for health.

Authors:  Guoyao Wu; Yun-Zhong Fang; Sheng Yang; Joanne R Lupton; Nancy D Turner
Journal:  J Nutr       Date:  2004-03       Impact factor: 4.798

4.  Total antioxidant capacity and the severity of the pain in patients with fibromyalgia.

Authors:  Ozlem Altindag; Hakim Celik
Journal:  Redox Rep       Date:  2006       Impact factor: 4.412

5.  [Morphology and pathogenesis of soft-tissue rheumatism].

Authors:  H G Fassbender; K Wegner
Journal:  Z Rheumaforsch       Date:  1973 Sep-Oct

Review 6.  Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease.

Authors:  B A Kingwell
Journal:  FASEB J       Date:  2000-09       Impact factor: 5.191

7.  Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population. A controlled study.

Authors:  K P White; M Speechley; M Harth; T Ostbye
Journal:  Scand J Rheumatol       Date:  2000       Impact factor: 3.641

Review 8.  Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment.

Authors:  Philip Mease
Journal:  J Rheumatol Suppl       Date:  2005-08

9.  Muscle tissue oxygen pressure in primary fibromyalgia.

Authors:  N Lund; A Bengtsson; P Thorborg
Journal:  Scand J Rheumatol       Date:  1986       Impact factor: 3.641

Review 10.  Fibromyalgia.

Authors:  Sangita Chakrabarty; Roger Zoorob
Journal:  Am Fam Physician       Date:  2007-07-15       Impact factor: 3.292

View more
  13 in total

1.  A quest for better understanding of biochemical changes in fibromyalgia syndrome.

Authors:  Abbas Ali Mahdi; Ghizal Fatima
Journal:  Indian J Clin Biochem       Date:  2013-11-20

2.  Effects of 12-week combined exercise therapy on oxidative stress in female fibromyalgia patients.

Authors:  Banu Sarıfakıoğlu; Aliye Yıldırım Güzelant; Eda Celik Güzel; Savaş Güzel; Ali Rıza Kızıler
Journal:  Rheumatol Int       Date:  2014-03-09       Impact factor: 2.631

Review 3.  Pathophysiology and antioxidant status of patients with fibromyalgia.

Authors:  Riffat Iqbal; M S Mughal; Najma Arshad; Muhammad Arshad
Journal:  Rheumatol Int       Date:  2010-04-08       Impact factor: 2.631

4.  Genetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patients.

Authors:  Cielito C Reyes-Gibby; Jian Wang; Margaret Spitz; Xifeng Wu; Sriram Yennurajalingam; Sanjay Shete
Journal:  J Pain Symptom Manage       Date:  2012-11-11       Impact factor: 3.612

5.  Nitric oxide, lipid peroxidation products, and antioxidants in primary fibromyalgia and correlation with disease severity.

Authors:  Varsha Shukla; Das Siddharth Kumar; Mahdi Abbas Ali; Shweta Agarwal; Sukhanshi Khandpur
Journal:  J Med Biochem       Date:  2020-01-23       Impact factor: 3.402

Review 6.  Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.

Authors:  Gerwyn Morris; George Anderson; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-06-13       Impact factor: 5.590

7.  Clinical symptoms in fibromyalgia are better associated to lipid peroxidation levels in blood mononuclear cells rather than in plasma.

Authors:  Mario D Cordero; Elísabet Alcocer-Gómez; Francisco J Cano-García; Manuel De Miguel; Angel M Carrión; Plácido Navas; José A Sánchez Alcázar
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

8.  The relationship between serum antioxidant vitamins, magnesium levels, and clinical parameters in patients with primary fibromyalgia syndrome.

Authors:  Sukran Tastan Sakarya; Yesim Akyol; Abdulkerim Bedir; Ferhan Canturk
Journal:  Clin Rheumatol       Date:  2011-02-24       Impact factor: 2.980

9.  Ambroxol for the treatment of fibromyalgia: science or fiction?

Authors:  Kai-Uwe Kern; Myriam Schwickert
Journal:  J Pain Res       Date:  2017-08-16       Impact factor: 3.133

10.  Dynamic Thiol/Disulphide Homeostasis in Patients With Fibromyalgia.

Authors:  Fatma Fidan; Berat Meryem Alkan; Fatma Gülçin Uğurlu; Sinem Bozkurt; Nebahat Sezer; Cemile Biçer; Özcan Erel; Özge Ardiçoğlu; Selami Akkuş
Journal:  Arch Rheumatol       Date:  2017-01-18       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.